Aurisco Pharmaceutical Co.,Ltd.

SSE:605116.SS

21.07 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q2
Assets:
Current Assets:
Cash & Cash Equivalents 736.603769.44877.055446.915533.57545.837520.988380.031434.577391.74320.831333.624420.114444.612507.348492.617501.215564.096633.667300.504-265.057265.057194.071
Short Term Investments 251.422299.83250.660-6.433-6.907-7.467-10.2240010.01710.02515.3030.17820.14120.135012.2812.272530.115040.338
Cash and Short Term Investments 988.0251,069.271,127.715446.915533.57545.837520.988380.031434.577391.74330.848343.649420.114444.612537.526512.759521.349564.096645.946312.776265.057265.057234.409
Net Receivables 398.272355.106366.727348.433292.694290.783269.475218.701241.648222.108240.757197.179132.711140.721144.524153.001166.058142.849114.37200135.1360
Inventory 614.823589.722581.476554.084513.929509.8494.493498.456440.81444.939393.477366.767363.729326.798285.671268.522257.462237.792235.085236.9690240.204236.415
Other Current Assets 21.1632.69820.25234.91213.02919.62126.03229.36931.53229.57130.09322.29724.72327.66927.21121.73527.54833.02221.949165.041024.457128.313
Total Current Assets 2,022.282,046.7962,096.1691,384.2631,353.2221,366.0411,302.0231,126.5581,144.3311,088.358995.174929.892941.276939.8992.318956.016972.418977.7591,013.32714.786265.057664.854599.137
Non-Current Assets:
Property, Plant & Equipment, Net 1,536.1121,497.1881,271.481,264.229946.811878.328754.479738.388693.269674.184642.933626.238611.569593.262556.884529.595507.183490.352438.233402.4090382.73342.245
Goodwill 00000000000000000000000
Intangible Assets 160.284161.458123.672119.991120.503121.396120.619121.259121.843122.712123.219124.01540.02740.41940.77641.10341.52141.93941.9142.154042.69932.53
Goodwill and Intangible Assets 160.284161.458123.672119.991120.503121.396120.619121.259121.843122.712123.219124.01540.02740.41940.77641.10341.52141.93941.9142.154042.69932.53
Long Term Investments -117.957-166.365-156.36179.29985.73286.20662.76765.52455.355.345.28345.275015.3-14.878-4.841-4.8350.3-11.98-11.97200.3-40.038
Tax Assets 17.0415.7859.79315.67315.51714.29515.26712.10611.62912.78310.35710.4798.5598.567.4767.8546.7676.30210.0656.51909.6657.392
Other Non-Current Assets 279.289322.56346.1626.04165.383108.345111.32982.13483.17279.50740.32747.112129.411124.09246.75436.70136.89516.5612.2812.272-265.057040.515
Total Non-Current Assets 1,874.7681,830.6261,594.7471,485.2321,333.9461,208.5691,064.4621,019.412965.214944.485862.119853.12789.567781.633637.011610.413587.531555.454490.507451.383-265.057435.394382.643
Total Assets 3,897.0483,877.4223,690.9162,869.4952,687.1682,574.6112,366.4852,145.972,109.5442,032.8431,857.2931,783.0121,730.8431,721.4331,629.3291,566.4291,559.9491,533.2131,503.8271,166.16901,100.248981.78
Liabilities & Equity:
Current Liabilities:
Account Payables 274.483358.677201.555325.71277.471173.584214.941184.521164.984115.179133.353123.479108.258137.277103.86898.1101.7297.04793.66975.429078.95191.501
Short Term Debt 40.03320.01730.03170.08845.28945.18440.05646.45235.59636.226003.640000000000
Tax Payables 29.79828.54616.54412.82725.70619.86517.210.54619.56814.95614.90431.25118.88910.57815.16814.91216.27318.29812.98820.392017.42413.599
Deferred Revenue 00016.066163.677173.317156.71137.052.2880.9772.5660050.7557.2552.244.361000000
Other Current Liabilities 93.559124.797289.642214.3126.366240.142150.778145.14121.033155.8129.82325.77122.71636.26319.47623.54213.79126.26522.82717.204020.26311.258
Total Current Liabilities 437.874532.037537.772622.925488.955501.024422.975381.547343.468322.172180.646180.501153.503193.078145.767136.554136.146141.61129.483113.0250116.638116.359
Non-Current Liabilities:
Long Term Debt 926.338922.191830.238130.593104.40571.69938.33713.9414.86616.4619.88616.90717.31513.9092.297006.76800000
Deferred Revenue Non-Current 92.06691.56645.31935.8536.3834.01834.48610.0627.8917.697.8187.8038.1134.5316.0655.61944.1374.2734.4104.3822.783
Deferred Tax Liabilities Non-Current 0.1940.19.3780.2790.0010.2842.0772.1762.2722.3621.9181.7611.9181.9182.0122.0762.2342.2341.9441.66701.9440.59
Other Non-Current Liabilities 000000010.062012.5010000000-2.63200000
Total Non-Current Liabilities 1,018.5981,013.857884.935130.872140.787106.00174.926.17825.02926.51229.62326.47127.34620.35910.3747.6956.2336.376.2186.07706.3273.373
Total Liabilities 1,456.4721,545.8941,422.707753.797629.742607.025497.875407.725368.498348.684210.268206.972180.849213.437156.141144.249142.379147.98135.701119.1020122.965119.732
Equity:
Preferred Stock 00000000000000000000000
Common Stock 406.195406.195406.195406.195406.195406.195406.195406.195406.195406.1954014014014014014014014014013600360360
Retained Earnings 1,242.2291,122.8111,076.131980.928963.883881.699847.618710.968725.94680.063672.144602.488578.733537.88514.002463.907461.624429.05425.678388.5360321.473219.848
Accumulated Other Comprehensive Income/Loss 000186.65733.063173.616671.942132.929658.085105.231569.78678.523565.95377.493556.59767.399554.94722.23822.1530977.28319.5570
Other Total Stockholders Equity 792.152802.523785.882506.075-45.716679.691-57.145610.643600.94589.910568.3970567.3670557.2730489.8740298.5310295.81282.2
Total Shareholders Equity 2,440.5762,331.5292,268.2092,079.8482,057.4251,967.5851,868.611,727.8061,733.0751,676.1681,642.931,571.8861,545.6851,506.2471,471.5991,422.181,417.571,385.2321,368.1261,047.067977.283977.283862.048
Total Equity 2,440.5762,331.5292,268.2092,079.8482,057.4251,967.5851,868.611,738.2451,741.0471,684.1591,647.0251,576.041,549.9941,507.9961,473.1881,422.181,417.571,385.2321,368.1261,047.067977.283977.283862.048
Total Liabilities & Shareholders Equity 3,897.0483,877.4223,690.9162,869.4952,687.1682,574.6112,366.4852,145.972,109.5442,032.8431,857.2931,783.0121,730.8431,721.4331,629.3291,566.4291,559.9491,533.2131,503.8271,166.169977.2831,100.248981.78